| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8563623 | Complementary Therapies in Medicine | 2016 | 15 Pages |
Abstract
BZYQT improves clinically important outcomes for patients with stable COPD, such as improved clinical symptoms, exercise capacity, lung function and quality of life. Moreover, it has an excellent safety profile. However further evaluation is needed to validate these preliminary findings in high quality RCTs.
Keywords
review managerFEV1MIPCBMCNKIRCTsTCMMCIDFVC6MWT95% CIRandomized controlled trialsSix-minute walking testChronic obstructive pulmonary diseaseCOPDChronic obstructive pulmonary disease (COPD)Cochrane Central Register of Controlled Trialsforced expiratory volume in one secondMinimal Clinically Important Differencemaximum inspiratory pressureChina National Knowledge Infrastructuretraditional Chinese medicineGlobal Initiative for Chronic Obstructive Lung DiseaseGoldforced vital capacity95% confidence intervalsMeta-analysisSystematic reviewCentralmean difference
Related Topics
Health Sciences
Medicine and Dentistry
Complementary and Alternative Medicine
Authors
Yuanbin Chen, Johannah Linda Shergis, Lei Wu, Xuhua Yu, Qigang Zeng, Yinji Xu, Xinfeng Guo, Anthony Lin Zhang, Charlie Changli Xue, Lin Lin,